Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Biochem Pharmacol. 2013 Aug 12;86(7):896–903. doi: 10.1016/j.bcp.2013.08.002

Table 1.

Specificity of biochanin A against mitogen-activated kinase related kinases.

Kinase Relative kinase activity (% of untreated control)
ASK1 (h) 103 ± 0
c-RAF (h) 86 ± 10
JNK1α1 (h) 98 ± 2
MAPK1 (h) 89 ± 4
MEK1 (h) 75 ± 7
MKK4 (m) 104 ± 3
MKK6 (h) 109 ± 5
MKK7β (h) 89 ± 6
MSK1 (h) 85 ± 5
PKBα (h) 101 ± 8
Rsk2 (h) 80 ± 5
SAPK2a (h) 88 ± 3
TAK1 (h) 91 ± 6
TAO1 (h) 80 ± 1
TAO2 (h) 84 ± 5